| Period Ending: |
LTM
(Last Twelve Months) |
2022 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2023-11-08 | 2023-04-14 | 2022-03-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0.783 | 0 | 0 |
| Gross Profit | -1.17 | -0.739 | 0 |
| Operating Expenses | -0.155 | 0 | 0.088 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 0 | 0 | 0.064 |
| Other Operating Expenses | -0.155 | 0 | 0.024 |
| Operating Income | -1.01 | -0.739 | -0.088 |
| Net Non-Operating Interest | 0 | 0 | 1.72 |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | -1.72 |
| Equity & Other Income/(Expense) | 7.15 | 16.25 | 0 |
| Income Before Tax | 6.14 | 15.51 | 1.63 |
| Income Tax Expense | -3.87 | -16.25 | -1.72 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | 10.01 | 31.77 | 3.36 |
| Depreciation and Amortization | -6.27 | -16.25 | 1.72 |
| EBITDA | -7.29 | -16.99 | 1.63 |
| Earnings Per Share (EPS) | 0.503 | 1.18 | 0.13 |
| Diluted Earnings Per Share | 0.503 | 1.18 | 0.13 |
| Weighted Average Shares Outstanding | 6.86 | 26.83 | 26.83 |
| Diluted Weighted Average Shares Outstanding | 6.86 | 26.83 | 26.83 |
